AI
Wednesday, July 19, 2023 5:59:25 PM
Clearly TTF + SOC delivered the results even worse than SOC. Likewise for the case of TTF + ICI and TTF + DTX except the case PD-L1 expression less than 1%.
The trial was a total failure!
https://www.novocure.com/lunar-phase-3-clinical-trial-demonstrates-statistically-significant-and-clinically-meaningful-extension-in-overall-survival-for-patients-with-metastatic-non-small-cell-lung-cancer-after-platinum-based/
Recent NVCR News
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
